Evidence map›Paper›PMID 40006687›Full record

ArticleVaccines2025

Cross-Reactive Fc-Mediated Antibody Responses to Influenza HA Stem Region in Human Sera Following Seasonal Vaccination.

Ayae Nishiyama, Takuto Nogimori, Yuji Masuta, Tomoka Matsuura, Tetsuo Kase, Kyoko Kondo, Satoko Ohfuji, Yu Nakagama, Natsuko Kaku, Sachie Nakagama and 6 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Vaccines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Ayae NishiyamaLaboratory of Precision Immunology, Center for Intractable Diseases and ImmunoGenomics, National Institutes of Biomedical Innovation, Health, and Nutrition, Osaka 567-0085, Japan.
Takuto NogimoriLaboratory of Precision Immunology, Center for Intractable Diseases and ImmunoGenomics, National Institutes of Biomedical Innovation, Health, and Nutrition, Osaka 567-0085, Japan.ORCID 0000-0002-6011-9631
Yuji MasutaLaboratory of Precision Immunology, Center for Intractable Diseases and ImmunoGenomics, National Institutes of Biomedical Innovation, Health, and Nutrition, Osaka 567-0085, Japan.ORCID 0000-0003-2349-6320
Tomoka MatsuuraDepartment of Public Health, Graduate School of Medicine, Osaka Metropolitan University, Osaka 545-8585, Japan.
Tetsuo KaseDepartment of Public Health, Graduate School of Medicine, Osaka Metropolitan University, Osaka 545-8585, Japan.
Kyoko KondoManagement Bureau, Osaka Metropolitan University Hospital, Osaka 545-8585, Japan.ORCID 0000-0003-1567-0667
Satoko OhfujiDepartment of Public Health, Graduate School of Medicine, Osaka Metropolitan University, Osaka 545-8585, Japan.ORCID 0000-0003-3239-5249
Yu NakagamaResearch Center for Infectious Disease Sciences, Graduate School of Medicine, Osaka Metropolitan University, Osaka 545-8585, Japan.
Natsuko KakuResearch Center for Infectious Disease Sciences, Graduate School of Medicine, Osaka Metropolitan University, Osaka 545-8585, Japan.
Sachie NakagamaResearch Center for Infectious Disease Sciences, Graduate School of Medicine, Osaka Metropolitan University, Osaka 545-8585, Japan.
Yuko NitaharaResearch Center for Infectious Disease Sciences, Graduate School of Medicine, Osaka Metropolitan University, Osaka 545-8585, Japan.
Yoshimasa TakahashiResearch Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo 162-8640, Japan.
Hiroshi KakeyaResearch Center for Infectious Disease Sciences, Graduate School of Medicine, Osaka Metropolitan University, Osaka 545-8585, Japan.ORCID 0000-0002-6251-1696
Yasutoshi KidoResearch Center for Infectious Disease Sciences, Graduate School of Medicine, Osaka Metropolitan University, Osaka 545-8585, Japan.ORCID 0000-0003-3615-2631
Wakaba FukushimaDepartment of Public Health, Graduate School of Medicine, Osaka Metropolitan University, Osaka 545-8585, Japan.
Takuya YamamotoLaboratory of Precision Immunology, Center for Intractable Diseases and ImmunoGenomics, National Institutes of Biomedical Innovation, Health, and Nutrition, Osaka 567-0085, Japan.ORCID 0000-0003-3753-1211

Funding

Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research (B) 24K02498The Japan Agency for Medical Research and Development JP23wm0125003the Ministry of Health, Labour and Welfare, Japan 20HA2001
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antibody-dependent cellular cytotoxicityantibody-dependent cellular phagocytosisinfluenza virusvaccine

Identifiers

PMID40006687
PMCPMC11860798

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.